中文 | ENG

第51卷 第5期 2018-10
Fishbone‑related liver abscess

.........................

第51卷 第5期 2018-10
Chest wall pleomorphic liposarcoma combined with lung extraskeletal osteosarcoma

.........................

第51卷 第5期 2018-10
Burkitt’s Lymphoma Presenting as Ovarian Mass and Ileocecal Intussusception in an Adult

.........................

第51卷 第5期 2018-10
Surgical versus conservative management for suppurative intramural esophageal dissection

.........................

第51卷 第5期 2018-10
Small cell carcinoma of upper urinary tract: A pooled analysis of survival

.........................

第51卷 第5期 2018-10
Improvement of satisfaction in burn patients receiving adjuvant hyperbaric oxygen therapy

.........................

第51卷 第5期 2018-10
Treatment results in the same surgery method of the high cervical spinal schwannoma

.........................

第51卷 第5期 2018-10
Chronic periodontal disease correlated with sezual function in young males

.........................

第51卷 第4期 2018-8
Idiopathic isolated omental panniculitis presenting with intestinal obstruction

.........................

第51卷 第4期 2018-8
Heterotopic subserosal pancreatic tissue in jejunum

.........................

第51卷 第4期 2018-8
Surgical intervention of a giant gastric gastrointestinal stromal tumor following neoadjuvant therapy with imatinib

.........................

第51卷 第4期 2018-8
Surgical treatment for duodeno‑reno‑cutaneous fistula

.........................

第51卷 第4期 2018-8
Laparoscopic liver resection for polycystic liver disease

.........................

第51卷 第4期 2018-8
The result of emergency cardiac intervention in resuscitated out‑of‑hospital cardiac arrest patients

.........................

第51卷 第4期 2018-8
The use of perforator flaps for the reconstruction of sacral defects: Ten-year experience

.........................

第51卷 第4期 2018-8
Chloroquine induces lysosomal membrane permeabilitymediated cell death in bladder cancer cells

.........................

第51卷 第3期 2018-6
Emphysematous gastritis after radical subtotal gastrectomy for advanced gastric cancer

.........................

第51卷 第3期 2018-6
Primary cervical spine melanoma

.........................

第51卷 第3期 2018-6
Jejunostomy tube-induced intussusception

.........................

第51卷 第3期 2018-6
Adult‑onset neurocutaneous melanosis with Dandy–Walker malformation

.........................
登入帳號才能閱讀全文
 
篇名 Differential impacts of clinical variables and 5‑fluorouracil‑based adjuvant chemotherapy on 5‑year disease‑free survival of patients with stage IIa and IIb colon cancer
作者 Yi‑Hung Kuo, Cheng‑Yi Huang, Chih‑Chien Chin, Chih‑Jung Chen, Wen‑Shih Huang, Jeng‑Fu You, Yun‑Ching Huang
卷期/出版年月 51卷2期 (2018/4)
頁次 41-49
摘要 Background: The aim of this study was to evaluate practicable predictors of 5‑year disease‑free survival (DFS) and impact of 5‑fluorouracil (5‑FU)‑based adjuvant chemotherapy in stage IIa and IIb colon cancer. Materials and Methods: A total of 1474 patients with stage II colon cancer were enrolled in study. The independent predictors of 5‑year DFS and the benefits of adjuvant chemotherapy were analyzed for patients with stage IIa (n = 771) and IIb (n = 703). Results: The incidences of pretreatment anemia, hypoalbuminemia, emergent surgery, and lymphovascular invasion (LVI) corresponded significantly to an advanced T‑stage in patients with stage II colon cancer. Although the incidence of surgical morbidity was not different between stage IIa and IIb, stage II patients with hypoalbuminemia had a higher incidence of surgical morbidity than did those with normal serum albumin (17.2% vs. 9.6%, P < 0.001). The co‑independent survival predictors in patients with stage IIa and IIb colon cancer were carcinoembryonic antigen (CEA < 5 ng/mL, P = 0.007 and 0.043), serum albumin (≥3.5 g/dL, P < 0.001 and P = 0.025), and nonsurgical morbidity (P < 0.001, both). Suboptimal lymph node harvest (<12 examined nodes, P < 0.001) and no adjuvant chemotherapy (P = 0.008) were poor prognostic factors only in stage IIb colon cancer. LVI showed a trend to worse DFS (P = 0.059). A survival benefit from adjuvant chemotherapy analyzed in four subgroups stratified by stage IIa and IIb, with or without the present prognostic factors, was only observed in patients with stage IIb colon cancer with hypoalbuminemia, abnormal CEA, suboptimal lymph node harvest, and postoperative morbidity. Conclusion: Different predictors of DFS were observed in stage IIa and IIb colon cancer; adjuvant chemotherapy could provide a survival benefit for patients with stage IIb colon cancer who have one of the four factors that were studied in our hospital‑based analysis.
關鍵詞 Adjuvant chemotherapy, carcinoembryonic antigen, hypoalbuminemia, morbidity, survival of stage II colon cancer
分類 Original Article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@24drs.com